POS EX - Tvardi Therapeutics, Inc. (0001346830) (Filer) Filing

From the Filing

EDGAR Filing Documents for 0001104659-26-038128 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]: SEC Accession No. 0001104659-26-038128 Filing Date 2026-04-01 Accepted 2026-04-01 06:07:44 Documents 2 Effectiveness Date 2026-04-01 Document Format Files Seq Description Document Type Size 1 POS EX tm2610047d2_posex.htm POS EX 34794 2 EXHIBIT 23.1 tm2610047d2_ex23-1.htm EX-23.1 1313 Complete submission text file 0001104659-26-038128.txt 37377 Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654 Tvardi Therapeutics, Inc. (Filer) CIK : 0001346830 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: POS EX | Act: 33 | File No.: 333-287675 | Film No.: 26824542 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)